Next Article in Journal
Clinical Relevance of Trace-Positive Results in Xpert MTB/RIF Ultra for Tuberculosis Diagnosis in a High-Burden Setting: A Retrospective Cohort Study
Previous Article in Journal
Hybrid Deep Learning Models for Analyzing Histological Images of the Zebrafish Intestine Under Oxidative Stress
Previous Article in Special Issue
Beyond Bone Mineral Density: Real-World Fracture Risk Profiles and Therapeutic Gaps in Postmenopausal Osteoporosis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Diagnostics
Volume 15
Issue 22
10.3390/diagnostics15222861
diagnostics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Diagnostics 2024, 14(4), 452.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Chen et al. Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis. Diagnostics 2024, 14, 452

by
Jia-Feng Chen
1,2,
Shan-Fu Yu
1,
Wen-Chan Chiu
1,
Chi-Hua Ko
1,
Chung-Yuan Hsu
1,
Han-Ming Lai
1,
Ying-Chou Chen
1,
Yu-Jih Su
1,
Hong-Yo Kang
2,3,4,5,*,† and
Tien-Tsai Cheng
1,*,†
1
Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, College of Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, Kaohsiung 833, Taiwan
2
Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Kaohsiung 833, Taiwan
3
Center for Menopause and Reproductive Medicine Research, Department of Obstetrics and Gynecology, College of Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, Kaohsiung 833, Taiwan
4
Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, Kaohsiung 833, Taiwan
5
Department of Biological Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Diagnostics 2025, 15(22), 2861; https://doi.org/10.3390/diagnostics15222861
Submission received: 30 October 2025 / Accepted: 5 November 2025 / Published: 12 November 2025
(This article belongs to the Special Issue Diagnosis and Management of Osteoporosis)
Browse Figure
Versions Notes
The authors are issuing a corrigendum for their article [1] to correct information within the Institutional Review Board Statement and the study period. These inaccuracies were the result of an administrative oversight.

Institutional Review Board Statement Correction

The IRB protocol code was erroneously stated. The correct IRB protocol code is 104-3530B, with an approval date of 13 July 2015. The corrected Institutional Review Board Statement appears below:
The study protocol was approved by the Regional Ethical Review Board of Chang Gung Memorial Hospital, Kaohsiung (protocol code: 104-3530B, date of approval: 13 July 2015). Data was collected from September 2015 through April 2021.

Text Correction

Corrections have been made to the study period in the Abstract, Materials and Methods Section and Figure 1: The study period was stated incorrectly. The data for this registry were collected at Chang Gung Memorial Hospital, Kaohsiung, Taiwan, from September 2015 to April 2021.
A correction has been made to the Abstract:
We utilized registry data gathered at Chang Gung Memorial Hospital in Kaohsiung, Taiwan, between September 2015 and April 2021.
A correction has been made to the Materials and Methods, paragraph 1:
A registry was compiled at Chang Gung Memorial Hospital, Kaohsiung (CGMHK), Taiwan, between September 2015 and April 2021.
The corrected Figure 1 appears below:
The scientific integrity and conclusions of the study remain unaffected by this correction. The authors regret any confusion this may have caused. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Chen, J.-F.; Yu, S.-F.; Chiu, W.-C.; Ko, C.-H.; Hsu, C.-Y.; Lai, H.-M.; Chen, Y.-C.; Su, Y.-J.; Kang, H.-Y.; Cheng, T.-T. Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis. Diagnostics 2024, 14, 452. [Google Scholar] [CrossRef] [PubMed]
Diagnostics 15 02861 g001
Figure 1. Disposition of participants. GC = glucocorticoid. * Exposure of therapy is defined as therapy exposure currently on the index day, or within the previous 6 months before the index day, or within the upcoming 6 months after the index day. Pharmacologic therapy included selective estrogen receptor modulators, oral or intravenous bisphosphonates, denosumab, and teriparatide.
Figure 1. Disposition of participants. GC = glucocorticoid. * Exposure of therapy is defined as therapy exposure currently on the index day, or within the previous 6 months before the index day, or within the upcoming 6 months after the index day. Pharmacologic therapy included selective estrogen receptor modulators, oral or intravenous bisphosphonates, denosumab, and teriparatide.
Diagnostics 15 02861 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chen, J.-F.; Yu, S.-F.; Chiu, W.-C.; Ko, C.-H.; Hsu, C.-Y.; Lai, H.-M.; Chen, Y.-C.; Su, Y.-J.; Kang, H.-Y.; Cheng, T.-T. Correction: Chen et al. Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis. Diagnostics 2024, 14, 452. Diagnostics 2025, 15, 2861. https://doi.org/10.3390/diagnostics15222861

AMA Style

Chen J-F, Yu S-F, Chiu W-C, Ko C-H, Hsu C-Y, Lai H-M, Chen Y-C, Su Y-J, Kang H-Y, Cheng T-T. Correction: Chen et al. Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis. Diagnostics 2024, 14, 452. Diagnostics. 2025; 15(22):2861. https://doi.org/10.3390/diagnostics15222861

Chicago/Turabian Style

Chen, Jia-Feng, Shan-Fu Yu, Wen-Chan Chiu, Chi-Hua Ko, Chung-Yuan Hsu, Han-Ming Lai, Ying-Chou Chen, Yu-Jih Su, Hong-Yo Kang, and Tien-Tsai Cheng. 2025. "Correction: Chen et al. Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis. Diagnostics 2024, 14, 452" Diagnostics 15, no. 22: 2861. https://doi.org/10.3390/diagnostics15222861

APA Style

Chen, J.-F., Yu, S.-F., Chiu, W.-C., Ko, C.-H., Hsu, C.-Y., Lai, H.-M., Chen, Y.-C., Su, Y.-J., Kang, H.-Y., & Cheng, T.-T. (2025). Correction: Chen et al. Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis. Diagnostics 2024, 14, 452. Diagnostics, 15(22), 2861. https://doi.org/10.3390/diagnostics15222861

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop